TY  - JOUR
T1  - OFf-label use of bone morphogenetic proteins in pediatric spinal arthrodesis
AU  - Dodwell E, Snyder B, Wright J
Y1  - 2012/10/10
N1  - 10.1001/jama.2012.12929
JO  - JAMA
SP  - 1429
EP  - 1432
VL  - 308
IS  - 14
N2  - 
Bone morphogenetic proteins (BMPs) are approved for limited use in adults when healing may be suboptimal.2- 3 In addition to concerns about possible carcinogenesis, complications include wound dehiscence, spinal stenosis, and respiratory complications.4 The US Food and Drug Administration has not approved the use of BMPs in children.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2012.12929
UR  - http://dx.doi.org/10.1001/jama.2012.12929
ER  -